Company attributes
Industry
Location
B2X
CEO
Pitchbook URL
Legal Name
Clene Inc.
Number of Employees (Ranges)
51 – 200
Email Address
info@clenenanomedicine.com0
info@CleneNanomedicine.com
Phone Number
+180167696950
Full Address
6550 South Millrock Drive, Suite G50 Salt Lake City, Utah 841210
500 Principio Parkway West Suite 400 North East, Maryland 219010
3165 East Millrock Drive, Suite 325, SALT LAKE CITY, UT 84121, US
CIK Number
Founded Date
January 1, 2012
Total Funding Amount (USD)
121,026,555
Latest Funding Round Date
December 2020
Stock Symbol
CLNN0
Exchange
Latest Funding Type
Patents Assigned (Count)
1
Country
Other attributes
Company Operating Status
Active
Latest Funding Round Amount (USD)
22,400,000
Ticker Symbol
CLNN
Clene is a clinical-stage biopharmaceutical company that focuses on developing unique therapeutics for neurodegenerative diseases. It innovated a novel nanotech drug platform for developing a new class of orally administered neurotherapeutic drugs.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.